Cargando…

Microbiome and Schizophrenia

Detalles Bibliográficos
Autor principal:	Akhondzadeh, Shahin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Avicenna Research Institute 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925402/ https://www.ncbi.nlm.nih.gov/pubmed/31908733

Ejemplares similares

Monoclonal Antibody for Reducing Memory and Learning Problems in Schizophrenia
por: Akhondzadeh, Shahin
Publicado: (2018)

Inflammation-Schizophrenia: A Bidirectional Causal Association Mediated by Cytokines
por: Shamabadi, Ahmad, et al.
Publicado: (2023)

Monoclonal Antibody a Promising Treatment for Depression
por: Akhondzadeh, Shahin
Publicado: (2019)

Depression and Inflammation: Is There any Role for Biomarkers?
por: Akhondzadeh, Shahin
Publicado: (2019)

Microbiota and Autism Spectrum Disorder
por: Akhondzadeh, Shahin
Publicado: (2019)

Ethical Issues in Medical Biotechnology
por: Akhondzadeh, Shahin
Publicado: (2014)

Iranian science shows world's fastest growth: ranks 17th in science production in 2012
por: Akhondzadeh, Shahin
Publicado: (2013)

Avicenna and Evidence Based Medicine
por: Akhondzadeh, Shahin
Publicado: (2014)

The Importance of Ethics in Medical Biotechnology
por: Akhondzadeh, Shahin
Publicado: (2015)

The Economic Aspects of Medical Biotechnology
por: Akhondzadeh, Shahin
Publicado: (2016)

Medical Biotechnology and Alzheimer’s Disease: New Hopes
por: Akhondzadeh, Shahin
Publicado: (2016)

Autistic Disorders and Medical Biotechnology
por: Akhondzadeh, Shahin
Publicado: (2015)

Personalized Medicine: A Tailor Made Medicine
por: Akhondzadeh, Shahin
Publicado: (2014)

US Editors and Reviewers can no Longer Handle Submissions by Authors Employed by the Government of Iran: Is it Fair and Logical?
por: Akhondzadeh, Shahin
Publicado: (2013)

Evidence Based Medicine and Medical Biotechnology
por: Akhondzadeh, Shahin
Publicado: (2015)

The Importance of Clinical Trials in Drug Development
por: Akhondzadeh, Shahin
Publicado: (2016)

Research Institutions without Walls
por: Akhondzadeh, Shahin
Publicado: (2014)

Research in Iran: Hopes and Disappointments
por: Akhondzadeh, Shahin
Publicado: (2017)

New Hopes for Treatment of Alzheimer’s Disease
por: Akhondzadeh, Shahin
Publicado: ( 201)

Innovation and Technology in Iran
por: Akhondzadeh, Shahin
Publicado: (2017)

Research in Iran: An Overview
por: Akhondzadeh, Shahin
Publicado: (2017)

Repositioning Drugs for Psychiatry
por: Akhondzadeh, Shahin
Publicado: (2020)

Basic Science and Clinical Studies on Non-COVID-19 Topics, of Coronavirus Victims
por: Akhondzadeh, Shahin, et al.
Publicado: (2021)

Medical Biotechnology in the Service of Coronavirus Vaccine Discovery and Production
por: Akhondzadeh, Shahin, et al.
Publicado: (2021)

Coronavirus Vaccination and Mortality in the Omicron Outbreak in Iran: Mortality Reduction due to Attenuated Pathogenicity and Booster Vaccine Doses
por: Shamabadi, Ahmad, et al.
Publicado: (2022)

Protection against the Omicron and Subsequent Coronavirus Variants: Medical-grade Masking, Third Dose Vaccination, Updating Vaccines, and Pursuing Universal Vaccine
por: Shamabadi, Ahmad, et al.
Publicado: (2022)

The Requisiteness for not Sacrificing Medical Biotechnology in the Coronavirus Era
por: Akhondzadeh, Shahin, et al.
Publicado: (2021)

Monkeypox Outbreaks in Non-Endemic Countries: What Do We Know and What Do We Need?
por: Shamabadi, Ahmad, et al.
Publicado: (2022)

Interdisciplinary Collaboration between Bench and Bedside in the COVID-19 Pandemic
por: Sanjari Moghaddam, Hossein, et al.
Publicado: (2023)

The Clinician Scientist Training Program in Iran: Catalyzing Clinical Science Advancements
por: Sanjari Moghaddan, Hosseein, et al.
Publicado: (2023)

Efficacy of Spironolactone as an Adjunctive Therapy to Risperidone to Improve Symptoms of Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled, Clinical Trial
por: Zandifar, Atefeh, et al.
Publicado: (2022)

Acetaminophen as Adjuvant to Risperidone in Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Arabzadeh, Somaye, et al.
Publicado: (2018)

Cardiovascular Effects of Saffron: An Evidence-Based Review
por: Kamalipour, Maryam, et al.
Publicado: (2011)

Resveratrol Adjunct Therapy for Negative Symptoms in Patients With Stable Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial
por: Samaei, Areoo, et al.
Publicado: (2020)

Microbiome yarns: microbiome basis of memory,,,
por: Timmis, Kenneth, et al.
Publicado: (2017)

Raloxifene adjunctive therapy for postmenopausal women suffering from chronic schizophrenia: a randomized double-blind and placebo controlled trial
por: Kianimehr, Gilda, et al.
Publicado: (2014)

The Meeting of Psychiatry and Humanities: An Overview
por: Akhondzadeh, Shahin, et al.
Publicado: (2009)

Oligodendrocytes in Schizophrenia
por: Xu, Haiyun, et al.
Publicado: (2011)

Microbiome in the clinic
Publicado: (2019)

The Human Microbiome
por: Plotnikoff, Gregory A., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_s9v13nhtj41q4o37opva6saigc